Top US Court to Hear Challenge to Purdue Pharma's $6 Billion Opioid Settlement
- The Supreme Court is hearing oral arguments regarding the approval of a controversial agreement by OxyContin-maker Purdue Pharma, which would provide billions of dollars to victims of the opioid epidemic while protecting the Sackler family from lawsuits.
- The deal involves the Sackler family paying between $5.5 billion to $6 billion to help fight the opioid crisis, with the majority going to states, local governments, and Native American tribes.
- If approved, the settlement would shield the Sackler family from future lawsuits and create a new company, Knoa Pharma, to distribute opioid addiction treatments and overdose reversal medicines.
Insights by Ground AI
Does this summary seem wrong?
0 Articles
0 Articles
All
Left
Center
Right
Coverage Details
Total News Sources0
Leaning Left38Leaning Right22Center76Last Updated8 months agoBias Distribution56% Center